Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arcadian Capital Management, commonly known as the Arcadian Fund, is a venture capital firm dedicated to the global cannabis and hemp industries. The firm focuses on ancillary businesses that provide critical infrastructure, technology, and services, including biotechnology, ag-tech, and healthcare applications. Arcadian provides strategic capital and operational support to early and growth-stage companies that are professionalizing the cannabis market. Their investment portfolio includes companies involved in cannabinoid research, data analytics, and specialized medical applications. By targeting the most scalable segments of the industry, Arcadian aims to drive innovation and institutional-grade growth within the cannabinoid sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arcadian Fund.